Home/Filings/4/0001209191-06-040268
4//SEC Filing

NASTECH PHARMACEUTICAL CO INC 4

Accession 0001209191-06-040268

$ATRXCIK 0000737207operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:17 PM ET

Size

8.8 KB

Accession

0001209191-06-040268

Insider Transaction Report

Form 4
Period: 2006-07-06
BRANDT GORDON
Exec VP of Science and Clinica
Transactions
  • Exercise/Conversion

    Nastech Pharmaceutical Company Inc Common Stock

    2006-07-06$8.89/sh+5,000$44,45017,500 total
  • Exercise of In-Money

    Nastech Pharmaceutical Company Inc Common Stock

    2006-07-06$8.89/sh5,000$44,450115,000 total
    Exercise: $8.89From: 2004-12-10Exp: 2013-12-10Common Stock (5,000 underlying)
  • Sale

    Nastech Pharmaceutical Company Inc Common Stock

    2006-07-06$15.43/sh5,000$77,12612,500 total

Issuer

NASTECH PHARMACEUTICAL CO INC

CIK 0000737207

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000737207

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:17 PM ET
Size
8.8 KB